| | | | | | | | | | |
|
|
|
| Dockets Entered
On December 12, 2003
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
| 2000N-1652
|
| Human Prescripton Drugs/Biologics in Electronic Format
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2002D-0428
|
| Information for the use of Human Blood & Blood Components
|
|
|
|
|
| 2003N-0084
|
| Electronic Records;Electronic Signatures;Agency Information
|
|
|
|
|
| 2003N-0308
|
| CIVIL MONEY PENALTIES HEARINGS; MAXIMUM PENALTY AMOUNTS AND Compliance with the FEDERAL CIVIL PENALTIES Inflation Adjustment Act
|
|
|
|
|
| 2003N-0324
|
| New Animal Drugs; Removal of Obsolete and Redundant Regulations
|
|
|
|
|
| 2003N-0324B
|
| Bacitracin methylene disalicylate single-ingredient Type A Medicated articles
|
|
|
|
|
| 2003N-0324N
|
| Combination drug Type B and TYpe C medicated feeds for poultry containing nicarbazin
|
|
|
|
|
| 2003N-0324O
|
| Oxytetracycline and neomycin fixed-combination Type A medicated articles
|
|
|
|
|
| 2003N-0324Z
|
| Combination drug Type B and Type C medicated feeds for poultry containing bacitracin zinc
|
|
|
|
|
| 2003P-0479
|
| Allow importation of Canadian versions of drugs that are approved to the United States
|
|
|
|
|
| 2003P-0511
|
| refrain from completing the review of the PMA submitted by Inamed Corporation(Inamed) for McGhan silicone gel-filled breast implants
|
|
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
|
|
| 2003P-0556
|
| ANDA for Dihydroergotamine Mesylate Injection
|
|
| |
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
11917
|
| Ancient Sun Nutrition, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11918
|
| Knature Corporation
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11919
|
| Knature Corporation
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11920
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11921
|
| Your Vitamins
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11922
|
| Worldwide Sport Nutrition Supplements, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11923
|
| Worldwide Sport Nutrition Supplements, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11924
|
| Worldwide Sport Nutrition Supplements, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11925
|
| Met-Rx USA, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11926
|
| Met-Rx USA, Inc.
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11927
|
| PhytoPharmica Matural Medicines
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11928
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 94
|
|
|
|
|
| LET
11929
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 94
|
|
| |
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| EMC 703
|
| B Anderson
|
| Vol #:
|
| 62
|
|
|
|
|
| EMC 704
|
| A Croymans
|
| Vol #:
|
| 62
|
|
| | | | | | | | |
|
|
|
|
| EMC 1
|
| B Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0324
|
| New Animal Drugs; Removal of Obsolete and Redundant Regulations
|
|
|
|
|
| ANS
1
|
| HF-11 to Buchanan Ingersoll
|
| Vol #:
|
| 1
|
|
| |
|
| 2003N-0324B
|
| Bacitracin methylene disalicylate single-ingredient Type A Medicated articles
|
|
|
|
|
| ANS
1
|
| HF-11 to Buchanan Ingersoll
|
| Vol #:
|
| 1
|
|
|
|
|
| CR
1
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| CR
2
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| EXT
1
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| HER
1
Attachment
|
| Pennfield Oil Company/Pennfield
Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| HER
2
|
| Alpharma Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| HFV-1 to Buchanan Ingersoll
|
| Vol #:
|
| 1
|
|
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| NPH
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SF
1
|
| GCF-1 (Separation of Functions)
|
| Vol #:
|
| 1
|
|
|
|
|
| SUP
1
|
| Pennfield Oil Company
|
| Vol #:
|
| 2
|
|
|
|
|
| SUP
2
|
| Alpharma Inc.
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003N-0324N
|
| Combination drug Type B and TYpe C medicated feeds for poultry containing nicarbazin
|
|
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| NPH
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SF
1
|
| GCF-1 Separation of Functions
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0324O
|
| Oxytetracycline and neomycin fixed-combination Type A medicated articles
|
|
|
|
|
| ANS
1
|
| HF-11 to Buchanan Ingersoll
|
| Vol #:
|
| 1
|
|
|
|
|
| CR
1
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| CR
2
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| EXT
1
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| HER
1
Attachment
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 1
|
|
|
|
|
| HER
2
|
| Alpharma Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| HFV-1 to Buchanan Ingersoll
|
| Vol #:
|
| 1
|
|
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| NPH
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SF
1
|
| GCF-1 Separation of Functions
|
| Vol #:
|
| 1
|
|
|
|
|
| SUP
1
|
| Pennfield Oil Company/Pennfield Animal Health
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003N-0324Z
|
| Combination drug Type B and Type C medicated feeds for poultry containing bacitracin zinc
|
|
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
|
|
| NPH
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SF
1
|
| GCF-1 Separation of Functions
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0479
|
| Allow importation of Canadian versions of drugs that are approved to the United States
|
|
|
|
|
| ACK 2
|
| HFA-305 to State of Vermont, Agency of Administration
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
2
|
| State of Vermont, Agency of Administration
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0511
|
| refrain from completing the review of the PMA submitted by Inamed Corporation(Inamed) for McGhan silicone gel-filled breast implants
|
|
|
|
|
| PDN 1
|
| HFZ-1 to National Organization for Women et al
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
|
|
| ACK 2
|
| HFA-305 to Worldclient
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 2
|
| J Huffman
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0556
|
| ANDA for Dihydroergotamine Mesylate Injection
|
|
|
|
|
| ACK 1
|
| HFA-305 to Hyman, Phelps & McNamara, PC
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
Tab 1,
2
|
| Hyman, Phelps & McNamara, PC
|
| Vol #:
|
| 1
|
|
